Warsaw, Ind.-based Zimmer Holdings regained some ground after analysts said the market “overreacted’’ to a study presented at a medical conference showing problems with one of the company’s knee implants. A Sanford C. Bernstein & Co. analyst told investors the study would not have a significant impact on sales. Zimmer is the world’s biggest maker of artificial hips and knee ... (Full article: 61 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
